Industry Research Reports

Home > Reports > Medical Care > Skin Cancer Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Skin Cancer Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 108 Pages

Report ld: 2337114

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Skin cancer is diagnosed by physical examination and biopsy. Biopsy is a quick and simple procedure where part or all of the spot is removed and sent to a laboratory.

The global market for Skin Cancer Diagnostics was estimated to be worth US$ 1274 million in 2023 and is forecast to a readjusted size of US$ 1861.4 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030

Skin Cancer Diagnostics Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Skin Cancer Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Skin Cancer Diagnostics by region & country, by Type, and by Application.

The Skin Cancer Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Cancer Diagnostics.

Market Segmentation

Report Metric
Details
Report Title
Skin Cancer Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 1861.4 million
CAGR(2024-2030)
5.5%
Market Size Available for Years
2019-2030
Global Skin Cancer Diagnostics Companies Covered
Alma Lasers, Agilent Technologies Inc, Biolitec AG, Bruker Corp, Ellipse A/S, GE Healthcare, Leica Microsystems, Michelson Diagnostics, Syneron Medical, Canon Medical Systems
Global Skin Cancer Diagnostics Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Skin Cancer Diagnostics Market, Segment by Type
Basal Cell Carcinoma

Squamous Cell Carcinoma

Malignant Melanoma

Others
Global Skin Cancer Diagnostics Market, Segment by Application
Hospital

Clinic

Laboratory

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Skin Cancer Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Skin Cancer Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Skin Cancer Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Skin Cancer Diagnostics Product Introduction
    1.2 Global Skin Cancer Diagnostics Market Size Forecast
    1.3 Skin Cancer Diagnostics Market Trends & Drivers
        1.3.1 Skin Cancer Diagnostics Industry Trends
        1.3.2 Skin Cancer Diagnostics Market Drivers & Opportunity
        1.3.3 Skin Cancer Diagnostics Market Challenges
        1.3.4 Skin Cancer Diagnostics Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Skin Cancer Diagnostics Players Revenue Ranking (2023)
    2.2 Global Skin Cancer Diagnostics Revenue by Company (2019-2024)
    2.3 Key Companies Skin Cancer Diagnostics Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Skin Cancer Diagnostics Product Offered
    2.5 Key Companies Time to Begin Mass Production of Skin Cancer Diagnostics
    2.6 Skin Cancer Diagnostics Market Competitive Analysis
        2.6.1 Skin Cancer Diagnostics Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Skin Cancer Diagnostics Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Cancer Diagnostics as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Basal Cell Carcinoma
        3.1.2 Squamous Cell Carcinoma
        3.1.3 Malignant Melanoma
        3.1.4 Others
    3.2 Global Skin Cancer Diagnostics Sales Value by Type
        3.2.1 Global Skin Cancer Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Skin Cancer Diagnostics Sales Value, by Type (2019-2030)
        3.2.3 Global Skin Cancer Diagnostics Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Laboratory
        4.1.4 Others
    4.2 Global Skin Cancer Diagnostics Sales Value by Application
        4.2.1 Global Skin Cancer Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Skin Cancer Diagnostics Sales Value, by Application (2019-2030)
        4.2.3 Global Skin Cancer Diagnostics Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Skin Cancer Diagnostics Sales Value by Region
        5.1.1 Global Skin Cancer Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Skin Cancer Diagnostics Sales Value by Region (2019-2024)
        5.1.3 Global Skin Cancer Diagnostics Sales Value by Region (2025-2030)
        5.1.4 Global Skin Cancer Diagnostics Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Skin Cancer Diagnostics Sales Value, 2019-2030
        5.2.2 North America Skin Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Skin Cancer Diagnostics Sales Value, 2019-2030
        5.3.2 Europe Skin Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Skin Cancer Diagnostics Sales Value, 2019-2030
        5.4.2 Asia Pacific Skin Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Skin Cancer Diagnostics Sales Value, 2019-2030
        5.5.2 South America Skin Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Skin Cancer Diagnostics Sales Value, 2019-2030
        5.6.2 Middle East & Africa Skin Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Skin Cancer Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Skin Cancer Diagnostics Sales Value
    6.3 United States
        6.3.1 United States Skin Cancer Diagnostics Sales Value, 2019-2030
        6.3.2 United States Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Skin Cancer Diagnostics Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Skin Cancer Diagnostics Sales Value, 2019-2030
        6.4.2 Europe Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Skin Cancer Diagnostics Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Skin Cancer Diagnostics Sales Value, 2019-2030
        6.5.2 China Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Skin Cancer Diagnostics Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Skin Cancer Diagnostics Sales Value, 2019-2030
        6.6.2 Japan Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Skin Cancer Diagnostics Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Skin Cancer Diagnostics Sales Value, 2019-2030
        6.7.2 South Korea Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Skin Cancer Diagnostics Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Skin Cancer Diagnostics Sales Value, 2019-2030
        6.8.2 Southeast Asia Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Skin Cancer Diagnostics Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Skin Cancer Diagnostics Sales Value, 2019-2030
        6.9.2 India Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Skin Cancer Diagnostics Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Alma Lasers
        7.1.1 Alma Lasers Profile
        7.1.2 Alma Lasers Main Business
        7.1.3 Alma Lasers Skin Cancer Diagnostics Products, Services and Solutions
        7.1.4 Alma Lasers Skin Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
        7.1.5 Alma Lasers Recent Developments
    7.2 Agilent Technologies Inc
        7.2.1 Agilent Technologies Inc Profile
        7.2.2 Agilent Technologies Inc Main Business
        7.2.3 Agilent Technologies Inc Skin Cancer Diagnostics Products, Services and Solutions
        7.2.4 Agilent Technologies Inc Skin Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
        7.2.5 Agilent Technologies Inc Recent Developments
    7.3 Biolitec AG
        7.3.1 Biolitec AG Profile
        7.3.2 Biolitec AG Main Business
        7.3.3 Biolitec AG Skin Cancer Diagnostics Products, Services and Solutions
        7.3.4 Biolitec AG Skin Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
        7.3.5 Bruker Corp Recent Developments
    7.4 Bruker Corp
        7.4.1 Bruker Corp Profile
        7.4.2 Bruker Corp Main Business
        7.4.3 Bruker Corp Skin Cancer Diagnostics Products, Services and Solutions
        7.4.4 Bruker Corp Skin Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
        7.4.5 Bruker Corp Recent Developments
    7.5 Ellipse A/S
        7.5.1 Ellipse A/S Profile
        7.5.2 Ellipse A/S Main Business
        7.5.3 Ellipse A/S Skin Cancer Diagnostics Products, Services and Solutions
        7.5.4 Ellipse A/S Skin Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
        7.5.5 Ellipse A/S Recent Developments
    7.6 GE Healthcare
        7.6.1 GE Healthcare Profile
        7.6.2 GE Healthcare Main Business
        7.6.3 GE Healthcare Skin Cancer Diagnostics Products, Services and Solutions
        7.6.4 GE Healthcare Skin Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
        7.6.5 GE Healthcare Recent Developments
    7.7 Leica Microsystems
        7.7.1 Leica Microsystems Profile
        7.7.2 Leica Microsystems Main Business
        7.7.3 Leica Microsystems Skin Cancer Diagnostics Products, Services and Solutions
        7.7.4 Leica Microsystems Skin Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
        7.7.5 Leica Microsystems Recent Developments
    7.8 Michelson Diagnostics
        7.8.1 Michelson Diagnostics Profile
        7.8.2 Michelson Diagnostics Main Business
        7.8.3 Michelson Diagnostics Skin Cancer Diagnostics Products, Services and Solutions
        7.8.4 Michelson Diagnostics Skin Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
        7.8.5 Michelson Diagnostics Recent Developments
    7.9 Syneron Medical
        7.9.1 Syneron Medical Profile
        7.9.2 Syneron Medical Main Business
        7.9.3 Syneron Medical Skin Cancer Diagnostics Products, Services and Solutions
        7.9.4 Syneron Medical Skin Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
        7.9.5 Syneron Medical Recent Developments
    7.10 Canon Medical Systems
        7.10.1 Canon Medical Systems Profile
        7.10.2 Canon Medical Systems Main Business
        7.10.3 Canon Medical Systems Skin Cancer Diagnostics Products, Services and Solutions
        7.10.4 Canon Medical Systems Skin Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
        7.10.5 Canon Medical Systems Recent Developments

 8 Industry Chain Analysis
    8.1 Skin Cancer Diagnostics Industrial Chain
    8.2 Skin Cancer Diagnostics Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Skin Cancer Diagnostics Sales Model
        8.5.2 Sales Channel
        8.5.3 Skin Cancer Diagnostics Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Skin Cancer Diagnostics Market Trends
    Table 2. Skin Cancer Diagnostics Market Drivers & Opportunity
    Table 3. Skin Cancer Diagnostics Market Challenges
    Table 4. Skin Cancer Diagnostics Market Restraints
    Table 5. Global Skin Cancer Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Skin Cancer Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Skin Cancer Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Skin Cancer Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Skin Cancer Diagnostics
    Table 10. Global Skin Cancer Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Cancer Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Skin Cancer Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Skin Cancer Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Skin Cancer Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Skin Cancer Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Skin Cancer Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Skin Cancer Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Skin Cancer Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Skin Cancer Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Skin Cancer Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Skin Cancer Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Skin Cancer Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Skin Cancer Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Skin Cancer Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Skin Cancer Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Skin Cancer Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Skin Cancer Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Skin Cancer Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Skin Cancer Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Alma Lasers Basic Information List
    Table 32. Alma Lasers Description and Business Overview
    Table 33. Alma Lasers Skin Cancer Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Skin Cancer Diagnostics Business of Alma Lasers (2019-2024)
    Table 35. Alma Lasers Recent Developments
    Table 36. Agilent Technologies Inc Basic Information List
    Table 37. Agilent Technologies Inc Description and Business Overview
    Table 38. Agilent Technologies Inc Skin Cancer Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Skin Cancer Diagnostics Business of Agilent Technologies Inc (2019-2024)
    Table 40. Agilent Technologies Inc Recent Developments
    Table 41. Biolitec AG Basic Information List
    Table 42. Biolitec AG Description and Business Overview
    Table 43. Biolitec AG Skin Cancer Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Skin Cancer Diagnostics Business of Biolitec AG (2019-2024)
    Table 45. Biolitec AG Recent Developments
    Table 46. Bruker Corp Basic Information List
    Table 47. Bruker Corp Description and Business Overview
    Table 48. Bruker Corp Skin Cancer Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Skin Cancer Diagnostics Business of Bruker Corp (2019-2024)
    Table 50. Bruker Corp Recent Developments
    Table 51. Ellipse A/S Basic Information List
    Table 52. Ellipse A/S Description and Business Overview
    Table 53. Ellipse A/S Skin Cancer Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Skin Cancer Diagnostics Business of Ellipse A/S (2019-2024)
    Table 55. Ellipse A/S Recent Developments
    Table 56. GE Healthcare Basic Information List
    Table 57. GE Healthcare Description and Business Overview
    Table 58. GE Healthcare Skin Cancer Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Skin Cancer Diagnostics Business of GE Healthcare (2019-2024)
    Table 60. GE Healthcare Recent Developments
    Table 61. Leica Microsystems Basic Information List
    Table 62. Leica Microsystems Description and Business Overview
    Table 63. Leica Microsystems Skin Cancer Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Skin Cancer Diagnostics Business of Leica Microsystems (2019-2024)
    Table 65. Leica Microsystems Recent Developments
    Table 66. Michelson Diagnostics Basic Information List
    Table 67. Michelson Diagnostics Description and Business Overview
    Table 68. Michelson Diagnostics Skin Cancer Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Skin Cancer Diagnostics Business of Michelson Diagnostics (2019-2024)
    Table 70. Michelson Diagnostics Recent Developments
    Table 71. Syneron Medical Basic Information List
    Table 72. Syneron Medical Description and Business Overview
    Table 73. Syneron Medical Skin Cancer Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Skin Cancer Diagnostics Business of Syneron Medical (2019-2024)
    Table 75. Syneron Medical Recent Developments
    Table 76. Canon Medical Systems Basic Information List
    Table 77. Canon Medical Systems Description and Business Overview
    Table 78. Canon Medical Systems Skin Cancer Diagnostics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Skin Cancer Diagnostics Business of Canon Medical Systems (2019-2024)
    Table 80. Canon Medical Systems Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Skin Cancer Diagnostics Downstream Customers
    Table 84. Skin Cancer Diagnostics Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Skin Cancer Diagnostics Product Picture
    Figure 2. Global Skin Cancer Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Skin Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Skin Cancer Diagnostics Report Years Considered
    Figure 5. Global Skin Cancer Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Skin Cancer Diagnostics Revenue in 2023
    Figure 7. Skin Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Basal Cell Carcinoma Picture
    Figure 9. Squamous Cell Carcinoma Picture
    Figure 10. Malignant Melanoma Picture
    Figure 11. Others Picture
    Figure 12. Global Skin Cancer Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Skin Cancer Diagnostics Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospital
    Figure 15. Product Picture of Clinic
    Figure 16. Product Picture of Laboratory
    Figure 17. Product Picture of Others
    Figure 18. Global Skin Cancer Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Skin Cancer Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Skin Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Skin Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Skin Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Skin Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Skin Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Skin Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Skin Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Skin Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Skin Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Skin Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Skin Cancer Diagnostics Sales Value (%), (2019-2030)
    Figure 31. United States Skin Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Skin Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Skin Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Skin Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Skin Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Skin Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Skin Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Skin Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Skin Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Skin Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Skin Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Skin Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Skin Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Skin Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Skin Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 52. Skin Cancer Diagnostics Industrial Chain
    Figure 53. Skin Cancer Diagnostics Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation

Skin cancer is diagnosed by physical examination and biopsy. Biopsy is a quick and simple procedure where part or all of the spot is removed and sent to a laboratory.

The global market for Skin Cancer Diagnostics was estimated to be worth US$ 1274 million in 2023 and is forecast to a readjusted size of US$ 1861.4 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030

Market Segmentation

Industry: Medical Care

Published: 2024-01-24

Pages: 108 Pages

Report ld: 2337114

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00